Drug intelligence / Profile preview

LAUR-008

Development stage
Unknown
Lead developer
Lauren Sciences
Modality
Nanoparticles → Drug Delivery Systems, Antibody-Based Therapeutics
Administration
Intravenous, Parenteral
01

Overview

LAUR-008 is a non-therapeutic, preclinical-stage proof-of-concept formulation developed by Lauren Sciences using its proprietary V-Smart® nanomedicine platform. It consists of V-Smart® nanovesicles (fabricated from synthetic bolaamphiphiles) encapsulating human immunoglobulin G (hIgG) antibody as a surrogate agent. LAUR-008 is designed to evaluate the platform's ability to non-invasively deliver large biological molecules, specifically antibodies, across the blood-brain barrier (BBB) into the brain via systemic administration. In preclinical studies, systemic administration of LAUR-008 demonstrated significantly higher brain delivery of hIgG compared to free hIgG, proving the platform's potential for CNS-targeted therapeutic delivery.

Other names
V-Smart-Human IgG AntibodyV-Smart-hIgGV-Smart-hIgG Antibody

Beyond the preview

Go deeper on LAUR-008.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LAUR-008.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call